ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 64 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $106,000 | -24.8% | 36,710 | -1.6% | 0.00% | – |
| Q4 2019 | $141,000 | -25.8% | 37,320 | +0.4% | 0.00% | – |
| Q3 2019 | $190,000 | -10.4% | 37,166 | +8.7% | 0.00% | – |
| Q2 2019 | $212,000 | +2.4% | 34,192 | +17.5% | 0.00% | – |
| Q1 2019 | $207,000 | -18.5% | 29,108 | -2.3% | 0.00% | -100.0% |
| Q4 2018 | $254,000 | -37.4% | 29,781 | +46.9% | 0.00% | 0.0% |
| Q3 2018 | $406,000 | -24.8% | 20,267 | -3.0% | 0.00% | 0.0% |
| Q2 2018 | $540,000 | +47.1% | 20,892 | +36.0% | 0.00% | 0.0% |
| Q1 2018 | $367,000 | -27.3% | 15,367 | +3.1% | 0.00% | 0.0% |
| Q4 2017 | $505,000 | +37.6% | 14,912 | -14.1% | 0.00% | 0.0% |
| Q3 2017 | $367,000 | +22.3% | 17,353 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $300,000 | -12.0% | 17,163 | -11.9% | 0.00% | 0.0% |
| Q1 2017 | $341,000 | +12.9% | 19,472 | +9.1% | 0.00% | 0.0% |
| Q4 2016 | $302,000 | +2.4% | 17,853 | -0.8% | 0.00% | 0.0% |
| Q3 2016 | $295,000 | +10.1% | 17,993 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $268,000 | +2.3% | 17,693 | -2.2% | 0.00% | 0.0% |
| Q1 2016 | $262,000 | -34.7% | 18,087 | +27.7% | 0.00% | 0.0% |
| Q4 2015 | $401,000 | +75.9% | 14,167 | +3.9% | 0.00% | 0.0% |
| Q3 2015 | $228,000 | -32.1% | 13,637 | +6.3% | 0.00% | 0.0% |
| Q2 2015 | $336,000 | – | 12,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|